Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AVBP | AZN | AMGN | GILD | BMY |
| Company | Arrivent Biopharma Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 30.32 | 202.81 | 351.89 | 138.95 | 59.20 |
| High | 30.72 | 205.30 | 356.69 | 139.76 | 60.48 |
| Low | 29.43 | 202.55 | 349.42 | 136.69 | 58.54 |
| Latest | 29.64 | 204.80 | 355.30 | 137.64 | 60.17 |
| Change | +0.03 | +4.33 | +5.91 | -0.91 | +1.21 |
| % Change | +0.10% | +2.16% | +1.69% | -0.66% | +2.05% |
| Volume | 397,600 | 1,241,300 | 3,686,000 | 7,345,800 | 11,535,800 |
| 20-Day Average Volume | 499,965 | 1,912,045 | 2,816,420 | 5,894,780 | 12,816,266 |
| Previous Close | 29.61 | 200.47 | 349.39 | 138.55 | 58.96 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 24.83 | 196.89 | 349.83 | 138.74 | 58.90 |
| 20-Day Raw Stochastic | 89.20% | 89.96% | 83.00% | 41.30% | 64.42% |
| 20-Day Relative Strength | 67.06 | 58.26 | 50.39 | 45.05 | 54.15 |
| Weighted Alpha | +58.81 | +48.05 | +26.76 | +31.34 | +30.86 |
| Today's Opinion | 100% Buy | 88% Buy | 56% Buy | 40% Buy | 80% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 40% Buy | 40% Buy | 64% Buy |
| Last Month's Opinion | 88% Buy | 56% Buy | 56% Buy | 80% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +16.42% since 04/10/26 | +0.38% since 04/10/26 | +1.22% since 04/10/26 | -0.97% since 04/10/26 | +2.64% since 04/10/26 |
| Low | 25.62 on 04/13/26 | 199.49 on 04/15/26 | 344.21 on 04/15/26 | 136.69 on 04/17/26 | 57.22 on 04/15/26 |
| High | 30.72 on 04/17/26 | 205.30 on 04/17/26 | 356.69 on 04/17/26 | 141.40 on 04/14/26 | 60.48 on 04/17/26 |
| 1-Month | |||||
| %Chg | +23.45% since 03/17/26 | +7.06% since 03/17/26 | -1.61% since 03/17/26 | -4.68% since 03/17/26 | +0.77% since 03/17/26 |
| Low | 20.72 on 03/30/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 30.72 on 04/17/26 | 207.30 on 04/10/26 | 360.68 on 03/18/26 | 143.79 on 03/18/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +42.09% since 01/16/26 | +8.49% since 01/16/26 | +7.53% since 01/16/26 | +10.19% since 01/16/26 | +8.89% since 01/16/26 |
| Low | 20.00 on 02/11/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 122.28 on 01/20/26 | 53.54 on 01/21/26 |
| High | 30.72 on 04/17/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +51.92% since 10/17/25 | +20.91% since 10/17/25 | +18.90% since 10/17/25 | +12.08% since 10/17/25 | +37.91% since 10/17/25 |
| Low | 17.00 on 11/03/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 30.72 on 04/17/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,310,147 | 317,625,952 | 191,750,080 | 170,841,792 | 122,851,192 |
| Shares Outstanding, K | 44,202 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -166,310,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -35,540,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.85 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.78 on 03/05/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/11/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.89 | 15.99 | 17.00 | 9.59 |